High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience. Kabut T, Weinbergerova B, Folber F, Lengerova M, et al. Bone Marrow Transplant 2023 Aug 23. doi: 10.1038/s41409-023-02081.

Read + Share

Amedeo Smart

Independent Medical Education

Kabut T, Weinbergerova B, Folber F, Lengerova M, et al. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience. Bone Marrow Transplant 2023 Aug 23. doi: 10.1038/s41409-023-02081.
PMID: 37612466